FindTrial
Sign In

Multi omics study on the pathogenesis of IgG4 related diseases

Multi omics study on the pathogenesis of IgG4 related diseases

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500105546
Enrollment
Unknown
Registered
2025-07-07
Start date
2025-07-07
Completion date
Unknown
Last updated
2025-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

IgG4 related diseases

Interventions

Control:None
IgG4-RD:None

Sponsors

Shanghai Changhai Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients in Shanghai Changhai hospital diagnosed with IgG4-RD and those highly suspected of having IgG4-RD.

Exclusion criteria

Exclusion criteria: Patients with other connective tissue diseases; Combined with other serious diseases such as hematological diseases, severe infections, malignant tumors, etc.

Design outcomes

Primary

MeasureTime frame
ESR;CRP;Serum IgG4;Lymphocyte subsets;Cytokine;Red blood cell count;White blood cell count;Platelet count;Antinuclear antibody;Anti-ENA antibody spectrum;Anti-liver antigen antibody spectrum;Anti-myositis antibody spectrum;CD3+/CD4+;CD3+/CD8+;CD3-/CD19+;CD3-CD16+CD56+;—

Secondary

MeasureTime frame
Gender;Age;Nation;Hospital stay;Family history;Past medical history;Smoking history;—

Countries

China

Contacts

Public ContactWan Wei

Shanghai Changhai Hospital

13916899863@163.com+86 139 1626 2814

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026